Search
for
Sort by
Research 961–990 of 1000+
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Successful treatment of resistant alopecia totalis with tofacitinib
- Treatment of Alopecia Areata and Its Numerous Possibilities: A Literature Review
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- 26 Characterization of a murine model of aa induced by adoptive transfer of cultured lymph node cells
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Systemic immunotherapies
- LB789 Novel IFNγ aptamer TAGX-0003 protected hair follicles from immune privilege collapse and reversed Alopecia Areata like phenotype in humanized mouse model
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Alopecia areata
- 034 Characterization of novel TMEM173 mutation causing a lupus- and SAVI-like phenotype, modified by polymorphisms in TMEM173 and IFIH1
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- In reply
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model
- SnapshotDx Quiz: March 2016
- Expression of Signal Transducer and Activator of Transcription-3 in Androgenetic Alopecia: A case control study
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Hair loss treatments take aim at the immune system
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Image 4_Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata.tif
- Image 3_Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata.tif
- Image 2_Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata.tif
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- 1323 The effects of 3-OH of kaempferol on interfollicular epidermal stem cell fate
- 1324 Impairment of hair-inducing capacity of 3D-cultured human dermal papilla cells by the ablation of STAT5